U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07230600) titled 'AD-SVF Therapy for Refractory Endometrial Infertility' on Nov. 13.
Brief Summary: The purpose of this study is to initially explore the efficacy of adipose-derived stromal vascular fraction (AD-SVF) therapy in the treatment of refractory endometrial infertility.
Study Start Date: Nov., 2025
Study Type: INTERVENTIONAL
Condition:
Endometrium; Atrophy
Intrauterine Synechiae
Intervention:
BIOLOGICAL: AD-SVF
AD-SVF is isolated and extracted from adipose tissue for intrauterine infusion therapy.
Recruitment Status: RECRUITING
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Information pro...